ARTICLE | Emerging Company Profile
Resolution: Fighting fibrosis with macrophages
Resolution is bringing macrophage cell therapies into the fibrosis arena
January 26, 2021 9:18 PM UTC
Macrophages are emerging as one of the hottest tools in the fight against cancer, but Resolution is targeting a new application for the cells: attacking fibrosis.
The Syncona-backed company launched in August with £26.6 million to develop macrophage cell therapies after the VC and the University of Edinburg Center for Regenerative Medicine concluded a two-year research collaboration assessing the commercial viability of the technology...